Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 2Phase 2/3 1

Status

Completed 6Unknown 4Terminated 1Active not recruiting 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Other hematologic neoplasm 1Lymphoid 1Dermatologic 1

Conditions

Breast Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Keratosis, Actinic 1Brain Concussion 1

Interventions

Cisplatin 267Oxaliplatin 194Carboplatin 189Capecitabine 183Docetaxel 176apatinib 164Paclitaxel 158Bevacizumab 155Gemcitabine 154Radiotherapy 146camrelizumab 145Fluorouracil 144Cyclophosphamide 123Irinotecan 119Drug Therapy 118sintilimab 107Etoposide 99anlotinib 90S 1 (combination) 88Leucovorin 85pembrolizumab 82Pemetrexed 78Doxorubicin 77toripalimab 76tislelizumab 75Dexamethasone 70Trastuzumab 65Neoadjuvant Therapy 64Rituximab 62Cetuximab 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Melatonin × Clear all
NCT04731974 2024-02-07

Acute Concussion and Melatonin

Children's National Research Institute

Phase 2 Unknown
254 enrolled
LymphoidOther hematologic neoplasm

Brain Concussion, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05740969 2023-02-23

PACKS

Zealand University Hospital

Phase 2 Unknown
48 enrolled
Dermatologic

Keratosis, Actinic

NCT02506777 2019-09-04

MBC1

N.N. Petrov National Medical Research Center of Oncology

Phase 2 Unknown
96 enrolled
Breast

Breast Neoplasms

NCT02506790 2019-09-04

Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast Cancer

N.N. Petrov National Medical Research Center of Oncology

Phase 2 Unknown
96 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡